Related Experiment Video

Updated: May 15, 2026

Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human Product
11:51

Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human Product

Published on: September 22, 2021

Immunotherapy of acute myeloid leukemia based on γδ T cells

Julie Gertner-Dardenne1, Cyril Fauriat, Norbert Vey

  • 1Aix-Marseille Université; Marseille, France ; Institut National de la Santé et de la Recherche Médicale; Centre de Recherche en Cancérologie de Marseille; Marseille, France ; Institut Paoli Calmettes; IBiSA Cancer Immunomonitoring Platform; Marseille, France.

Oncoimmunology
|December 25, 2012
PubMed

A current major challenge of acute myeloid leukemia research is to develop immunotherapeutic strategies that would be employable in all patients. We recently reported that appropriately stimulated γδ T cells are fully capable of mediating cytotoxicity against leukemic blasts.

More Related Videos

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate13:08

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.